Today: 19 April 2026
Sembcorp share price ends week higher as Alinta vote and Feb 25 results line up
18 January 2026
1 min read

Sembcorp share price ends week higher as Alinta vote and Feb 25 results line up

Singapore, Jan 18, 2026, 15:29 SGT — Market closed

  • On Friday, Sembcorp shares ended the day 2.3% higher, closing at S$6.12
  • Shareholders will cast their votes on the Alinta Energy acquisition proposal on Jan 30; proxy submissions are due by Jan 27
  • FY2025 results will be released Feb 25 before the market opens, followed by a briefing webcast later that morning

Sembcorp Industries Ltd (SGX:U96) shares climbed 2.3% to close at S$6.12 on Friday, with roughly 6.1 million shares changing hands. The pause in trading on Sunday means attention now turns to a key deal vote and when the company will release its full-year results.

This matters now because the proposed acquisition in Australia would reshape Sembcorp’s portfolio, add debt, and force the company to reset its climate targets. The stock has been trading on “deal versus dilution” math, and these next dates are where that debate gets tested in public.

Sembcorp is set to report its FY2025 financial results before markets open on Feb 25. A live webcast of the results briefing will follow at 11 a.m. Singapore time.

The shareholder vote takes priority. According to an SGX filing, Sembcorp plans an extraordinary general meeting on Jan 30 at 10 a.m., held at the Fairmont Hotel in Singapore. Proxy submissions must be in by 10 a.m. on Jan 27.

In a circular to shareholders, Sembcorp set the agreed enterprise value — which includes debt — at A$6.5 billion (around S$5.6 billion) and confirmed it will pay cash on completion. The company plans to arrange long-term debt financing but has lined up a fully committed A$6.5 billion bridge facility, a short-term bank loan, to cover the purchase if longer-term debt isn’t secured in time. The circular highlighted Alinta’s 10.4-gigawatt development pipeline along with pro forma boosts to earnings per share and return on equity. On the flip side, Sembcorp expects pro forma emissions intensity to climb to about 0.36 tonnes of CO2 equivalent per megawatt hour and absolute emissions to 18.1 million tonnes of CO2e by 2025. It also acknowledged it would miss its 2028 and 2030 targets, while aiming for a 0.26 tCO2e/MWh intensity target by 2035 and net zero (Scope 1 and 2) by 2050.

Citi Research analyst Luis Hilado described the deal as both “half-full” and “half-empty,” noting it might boost earnings but hinder Sembcorp’s decarbonisation efforts. The Business Times

The journey from vote to completion isn’t always smooth. Rising funding costs, stricter Australian regulations, or delays in securing financing could all reshape expected returns and fuel stock volatility.

Traders have a clear short-term focus: proxy flows into Jan 27, followed by the Jan 30 vote. After those dates, the spotlight moves sharply to Feb 25 — not just the numbers, but crucially any updates on leverage, funding mix, and management’s strategy for balancing growth against the updated emissions profile.

Stock Market Today

  • Nordea Bank Abp's Mixed Share Performance and Valuation Analysis
    April 18, 2026, 10:42 PM EDT. Nordea Bank Abp (HLSE:NDA FI) exhibits mixed returns with a negative year-to-date but a 51.1% total return over one year, showing strong long-term momentum. The bank's share price closed at €16.02, slightly below the €16.55 analyst target and a fair value estimate of €17.03, suggesting it may be undervalued. Nordea is investing heavily in digital technologies and cybersecurity, aiming to improve net margins and fee income. However, potential risks include Nordic housing market weakness and rising regulatory costs. Investors are advised to weigh both upside potential and downside risks before making decisions, considering broader financial sector comparisons and market conditions.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Seatrium share price in focus after U.S. court revives Empire Wind; Feb 28 delivery watched
Previous Story

Seatrium share price in focus after U.S. court revives Empire Wind; Feb 28 delivery watched

Singapore Airlines stock price: Air India pact in focus after C6L closes at S$6.35
Next Story

Singapore Airlines stock price: Air India pact in focus after C6L closes at S$6.35

Go toTop